PACS Group, Inc. (PACS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PACS SEC filings page.
PACS Group, Inc. (PACS) reported $5.6B in revenue over the twelve months to Jun 30, 2026, up 15.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Rapid sales expansion temporarily squeezed margins, but FY2025 shows better cost absorption, stronger cash conversion, and a sturdier balance sheet.
Operating margin recovered from3.0% in FY2024 to5.9% in FY2025 as revenue expanded faster than SG&A. That pattern indicates growth was absorbed more efficiently after the prior year's cost pressure, rather than merely reflecting larger sales.
FY2025 net income of
The balance sheet became less debt-dependent: debt-to-equity fell from 2.0x in FY2023 to 0.3x in FY2025 as equity expanded. Current ratio improved from 1.0x to 1.1x, indicating the short-term liquidity pressure visible in FY2024 eased by FY2025.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of PACS Group, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
PACS Group, Inc. has an operating margin of 5.9%, meaning the company retains $6 of operating profit per $100 of revenue. This results in a moderate score of 54/100, indicating healthy but not exceptional operating efficiency. This is up from 3.0% the prior year.
PACS Group, Inc.'s revenue surged 29.3% year-over-year to $5.3B, reflecting rapid business expansion. This strong growth earns a score of 90/100.
PACS Group, Inc. carries a low D/E ratio of 0.26, meaning only $0.26 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 72/100, indicating a strong balance sheet with room for future borrowing.
PACS Group, Inc.'s current ratio of 1.07 is below the typical benchmark, resulting in a score of 22/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Not available for PACS Group, Inc., and counted as zero in the overall score.
PACS Group, Inc.'s ROE of 20.2% shows moderate profitability relative to equity, earning a score of 55/100. This is up from 7.9% the prior year.
PACS Group, Inc. scores 2.11, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
PACS Group, Inc. passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, PACS Group, Inc. generates $2.11 in operating cash flow ($404.2M OCF vs $191.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
PACS Group, Inc. earns $10.92 in operating income for every $1 of interest expense ($309.6M vs $28.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
PACS Group, Inc. generated $1.4B in revenue in Q2 2026. This represents an increase of 9.1% from the same quarter a year earlier. Against the prior quarter it is up 0.5%.
PACS Group, Inc. reported $76.4M in net income in Q2 2026. This represents an increase of 49.9% from the same quarter a year earlier. Against the prior quarter it is down 5.4%.
PACS Group, Inc. earned $0.47 per diluted share (EPS) in Q2 2026. This represents an increase of 51.6% from the same quarter a year earlier. Against the prior quarter it is down 6.0%.
Not reported for Q2 2026.
Cash & Balance Sheet
PACS Group, Inc. held $164.5M in cash against $238.7M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
PACS Group, Inc.'s gross margin was 23.7% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.
PACS Group, Inc.'s operating margin was 7.7% in Q2 2026, reflecting core business profitability. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.
PACS Group, Inc.'s net profit margin was 5.3% in Q2 2026, showing the share of revenue converted to profit. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.3 percentage points.
PACS Group, Inc.'s ROE was 6.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.9 percentage points.
Capital Allocation
None of these metrics is reported for Q2 2026.
PACS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4B+9.1% | $1.4B+11.2% | $1.4B+12.4% | $1.3B+31.0% | $1.3B+39.9% | $1.3B+38.8% | $1.2B+41.6% | $1.0B+30.0% |
| Cost of Revenue | $1.1B+6.7% | $1.1B+5.0% | $1.0B+9.4% | $1.0B+23.1% | $1.0B+33.9% | $1.0B+39.1% | $949.4M+39.7% | $849.6M+33.1% |
| Gross Profit | $338.5M+17.4% | $346.0M+36.5% | $319.2M+23.5% | $298.3M+68.8% | $288.4M+66.1% | $253.4M+37.8% | $258.5M+49.0% | $176.7M+17.3% |
| SG&A Expenses | $114.3M+13.9% | $112.3M+13.8% | $113.5M+26.6% | $102.5M+45.3% | $100.3M-26.6% | $98.7M+110.5% | $89.6M+113.6% | $70.6M+42.4% |
| Operating Income | $109.3M+35.8% | $120.0M+149.3% | $94.7M+31.5% | $86.3M+275.7% | $80.5M+316.5% | $48.1M-26.3% | $72.0M+15.1% | $23.0M-36.9% |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $33.5M-21.7% |
| Interest Expense | $6.0M+38.8% | $6.4M-7.0% | $8.6M-7.8% | $8.5M-5.5% | $4.4M-56.1% | $6.9M-57.1% | $9.3M | $9.0M-11.6% |
| Income Tax | $29.5M+6.7% | $33.1M+130.4% | $27.0M+8.1% | $24.0M+37.4% | $27.6M+244.6% | $14.3M-37.3% | $25.0M+65.7% | $17.4M+133.6% |
| Net Income | $76.4M+49.9% | $80.7M+183.4% | $59.7M+60.5% | $52.4M+235.5% | $51.0M+259.9% | $28.5M-18.2% | $37.2M+9.0% | $15.6M-21.6% |
| EPS (Basic) | $0.48+45.5% | $0.51+183.3% | $0.39+56.0% | $0.33+230.0% | $0.33+257.1% | $0.18-33.3% | $0.25-7.4% | $0.10-33.3% |
| EPS (Diluted) | $0.47+51.6% | $0.50+194.1% | $0.42+68.0% | $0.32+220.0% | $0.31+247.6% | $0.17-37.0% | $0.25-7.4% | $0.10-33.3% |
| Diluted Shares (Avg) | 162M-2.1% | 162M-2.6% | N/A | 165M+3.9% | 165M+10.7% | 166M+29.3% | N/A | 158M+23.1% |
Not reported in any period shown, so not listed: R&D Expenses.
PACS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.7B+2.8% | $5.7B+3.1% | $5.6B+6.5% | $5.6B+24.6% | $5.5B+39.9% | $5.5B+42.3% | $5.2B+49.3% | $4.5B |
| Current Assets | $962.4M-10.7% | $1.1B-1.2% | $1.1B+14.0% | $1.1B+53.3% | $1.1B+41.1% | $1.1B+31.8% | $938.3M+29.9% | $734.8M |
| Cash & Equivalents | $164.5M-44.1% | $248.0M-13.7% | $197.0M+25.0% | $355.7M+618.3% | $294.2M+300.9% | $287.5M+254.0% | $157.7M+114.8% | $49.5M-28.3% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $634.5M-0.6% | $648.0M-4.8% | $628.1M-2.1% | $628.3M+9.3% | $638.1M+10.0% | $680.7M+11.3% | $641.8M+17.2% | $574.6M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $61.8M | $61.8M | $61.8M+1.6% | N/A | N/A | N/A | $60.8M+3.0% | N/A |
| Total Liabilities | $4.5B-3.2% | $4.6B-2.5% | $4.6B+2.3% | $4.7B+23.4% | $4.7B+38.3% | $4.7B+26.6% | $4.5B+32.7% | $3.8B |
| Current Liabilities | $1.1B-9.6% | $1.1B-3.1% | $1.0B+2.4% | $1.2B+75.7% | $1.2B+139.1% | $1.1B+106.8% | $978.4M+114.1% | $681.7M |
| Non-Current Liabilities | $3.5B-1.0% | $3.5B-2.3% | $3.6B+2.3% | $3.6B+12.1% | $3.5B+21.4% | $3.6B+13.3% | $3.5B+20.1% | $3.2B |
| Long-Term Debt | $238.7M-3.4% | $239.8M-3.7% | $244.8M-2.5% | $245.9M-3.1% | $247.0M+8.8% | $249.1M+7.9% | $251.0M+28.2% | $253.6M |
| Total Equity | $1.1B+37.6% | $1.0B+38.2% | $946.8M+33.4% | $871.3M+32.0% | $806.8M+50.3% | $750.2M+560.0% | $709.6M+638.1% | $660.0M+735.6% |
| Retained Earnings | $466.6M+136.3% | $390.3M+166.4% | $309.6M+162.3% | $249.9M+209.1% | $197.5M+202.8% | $146.5M+29.3% | $118.0M+23.0% | $80.8M |
Not reported in any period shown, so not listed: Inventory.
PACS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $135.5M+157.7% | $236.3M+57.3% | -$3.4M-105.2% | $204.8M-2.1% | $52.6M+51.2% | $150.2M+155.7% | $64.6M+765.8% | $209.2M+1277.8% |
| Depreciation & Amortization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $10.5M+65.4% |
| Stock-Based Compensation | $25.8M+89.9% | $20.3M+66.8% | N/A | $12.5M+1.7% | $13.6M-85.0% | $12.2M | N/A | $12.3M |
| Investing Cash Flow | -$155.7M-380.6% | -$127.0M-673.4% | -$118.1M-13.2% | -$97.1M+1.7% | -$32.4M+73.2% | -$16.4M+86.2% | -$104.3M-74.0% | -$98.7M-116.6% |
| Financing Cash Flow | -$76.6M-483.1% | -$67.7M-1565.8% | -$5.5M-103.9% | -$46.3M+63.3% | -$13.1M-118.6% | -$4.1M-111.8% | $138.6M+41.1% | -$126.4M-415.7% |
| Dividends Paid | N/A | N/A | $0 | $0 | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.
PACS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 23.7%+1.7pp | 24.3%+4.5pp | 23.5%+2.1pp | 22.2%+5.0pp | 22.0%+3.5pp | 19.8%-0.2pp | 21.4%+1.1pp | 17.2%-1.9pp |
| Operating Margin | 7.7%+1.5pp | 8.5%+4.7pp | 7.0%+1.0pp | 6.4%+4.2pp | 6.2%+10.1pp | 3.8%-3.3pp | 6.0%-1.4pp | 2.2%-2.4pp |
| Net Margin | 5.3%+1.5pp | 5.7%+3.5pp | 4.4%+1.3pp | 3.9%+2.4pp | 3.9%+7.3pp | 2.2%-1.6pp | 3.1%-0.9pp | 1.5%-1.0pp |
| Return on Equity | 6.9%+0.6pp | 7.8%+4.0pp | 6.3%+1.1pp | 6.0%+3.6pp | 6.3%+12.3pp | 3.8%-26.8pp | 5.2%-30.3pp | 2.4%-22.8pp |
| Return on Assets | 1.4%+0.4pp | 1.4%+0.9pp | 1.1%+0.4pp | 0.9%+0.6pp | 0.9%+1.7pp | 0.5%-0.4pp | 0.7%-0.3pp | 0.4% |
| Current Ratio | 0.910.0x | 0.990.0x | 1.07+0.1x | 0.94-0.1x | 0.92-0.6x | 0.98-0.6x | 0.96-0.6x | 1.08 |
| Debt-to-Equity | 0.21-0.1x | 0.23-0.1x | 0.26-0.1x | 0.28-0.1x | 0.31-0.1x | 0.33-1.7x | 0.35-1.7x | 0.38 |
| Asset Turnover | 0.250.0x | 0.250.0x | 0.240.0x | 0.240.0x | 0.240.0x | 0.230.0x | 0.230.0x | 0.23 |
Not reported in any period shown, so not listed: FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| PACS Group, Inc. PACS | FY2025 | $5.3B | $191.5M | 3.6% | $6.9B | 49/100 |
| SELECT MEDICAL HOLDINGS CORP SEM | FY2025 | $5.5B | $146.2M | 2.7% | $2.0B | 40/100 |
| National Healthcare Corp. NHC | FY2025 | $1.5B | $120.0M | 7.9% | $3.5B | 67/100 |
| Ardent Health, Inc. ARDT | FY2025 | $6.3B | $135.8M | 2.1% | $1.6B | 28/100 |
| Aveanna Healthcare Holdings Inc. AVAH | FY2026 | $2.4B | $225K | 0.0% | $2.7B | 36/100 |
| Pediatrix Medical Group, Inc. MD | FY2025 | $1.9B | $165.4M | 8.6% | $2.1B | 35/100 |
Where PACS Group, Inc. Ranks
Frequently Asked Questions
What is PACS Group, Inc.'s annual revenue?
PACS Group, Inc. (PACS) reported $5.3B in total revenue for fiscal year 2025. This represents a 29.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is PACS Group, Inc.'s revenue growing?
PACS Group, Inc. (PACS) revenue grew by 29.3% year-over-year, from $4.1B to $5.3B in fiscal year 2025.
Is PACS Group, Inc. profitable?
Yes, PACS Group, Inc. (PACS) reported a net income of $191.5M in fiscal year 2025, with a net profit margin of 3.6%.
How much debt does PACS Group, Inc. have?
As of fiscal year 2025, PACS Group, Inc. (PACS) had $197.0M in cash and equivalents against $244.8M in long-term debt.
What is PACS Group, Inc.'s gross margin?
PACS Group, Inc. (PACS) had a gross margin of 21.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is PACS Group, Inc.'s operating margin?
PACS Group, Inc. (PACS) had an operating margin of 5.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is PACS Group, Inc.'s net profit margin?
PACS Group, Inc. (PACS) had a net profit margin of 3.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is PACS Group, Inc.'s return on equity (ROE)?
PACS Group, Inc. (PACS) has a return on equity of 20.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is PACS Group, Inc.'s operating cash flow?
PACS Group, Inc. (PACS) generated $404.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are PACS Group, Inc.'s total assets?
PACS Group, Inc. (PACS) had $5.6B in total assets as of fiscal year 2025, including both current and long-term assets.
What is PACS Group, Inc.'s current ratio?
PACS Group, Inc. (PACS) had a current ratio of 1.07 as of fiscal year 2025, which is considered adequate.
What is PACS Group, Inc.'s debt-to-equity ratio?
PACS Group, Inc. (PACS) had a debt-to-equity ratio of 0.26 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is PACS Group, Inc.'s return on assets (ROA)?
PACS Group, Inc. (PACS) had a return on assets of 3.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is PACS Group, Inc.'s P/E ratio?
PACS Group, Inc. (PACS) trades at 25.5x earnings, its market capitalization divided by net income of $269.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $6.9B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is PACS Group, Inc.'s price-to-sales ratio?
PACS Group, Inc. (PACS) trades at 1.2x sales, its market capitalization divided by revenue of $5.6B revenue, trailing 12 months to June 30, 2026. The market capitalization is $6.9B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is PACS Group, Inc.'s Altman Z-Score?
PACS Group, Inc. (PACS) has an Altman Z-Score of 2.11, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is PACS Group, Inc.'s Piotroski F-Score?
PACS Group, Inc. (PACS) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are PACS Group, Inc.'s earnings high quality?
PACS Group, Inc. (PACS) has an earnings quality ratio of 2.11x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can PACS Group, Inc. cover its interest payments?
PACS Group, Inc. (PACS) has an interest coverage ratio of 10.92x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is PACS Group, Inc.?
PACS Group, Inc. (PACS) scores 49 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.